Pharmaceuticals

FDA Approves Positrigo’s NeuroLF Brain PET System for Diagnosis of Multiple Brain Disorders

bexib
By bexib 0 Min Read

With the approval of the NeuroLF Brain PET System, Positrigo has become the first device of its kind to be approved in the United States.

You Might Also Like

NHS to roll out fiber optic laser treatment to prevent seizures in epilepsy patients

Avoiding the pharma “junk pile” with launch prep, tighter pipeline and “fast acquisitions”

EpiEndo and AlveoliX Achieve Breakthrough in Ulcerative Colitis Treatment

Non-compete clauses and the nursing shortage: Q&A with Matt Hollingsworth

BioMarin hires Amgen, Roche veterans to top executive posts

Share This Article
Previous Article HSBC’s new Chinese-speaking CEO unveils British bank’s deepening pivot to Asia
Next Article Chinese Overcapacity Played a Role in a Steel Plant Closure in Oregon
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Revolut launches robo-advisor in Singapore
Fintech
This hurricane season, do your customers know the difference between homeowners insurance and flood insurance?
Insurance
Crypto.com launches US institutional exchange
Fintech
Trafalgar St James unveils Rockwell Bistro & Wine Bar; first phase of hotel’s £6m refurbishment
Hospitality & Tourism